Some patients may choose to stay on a lower maintenance dose of GLP-1s long-term
Dose adjustments and titration protocol changes are normal parts of GLP-1 treatment management and can often address tolerability issues
That means COAs, third-party testing, community reviews, and systematic vendor evaluation become your quality assurance system
Hirai H, Launey T, Mikawa S, Torashima T, Yanagihara D, Kasaura T, Miyamoto A, Yuzaki M
This article examines the evidence regarding tirzepatide and allodynia, reviews common adverse effects, and provides guidance on when neurological symptoms require medical evaluation
Perhaps most concerning, a 25-year ARIC cohort study published in eBioMedicine of over 11,000 adults found that chronic under-hydration was linked to a 39% increased risk of chronic diseases, 1015% higher odds of being biologically older than your actual age, and elevated risk of early death